No Controversy Here

While controversy exists in the USA concerning research with embryonic stem cells, everyone agrees that using adult stem cells are appropriate and efficacious. Rabin Medical Center has made a major breakthrough in applying adult stem cells to treat Parkinson's disease by developing NurOwn, a technology that generates neuron-like cells derived from human bone marrow. Using the patient's own bone marrow to supply dopamineproducing cells circumvents problems of immunity and compatibility. Credit for the discovery goes to Prof. Eldad Melamed, Director of Neurology at the Rabin Medical Center and member of the Michael J. Fox Foundation for Parkinson's Research, together with Dr. Daniel Offen, Director of Laboratory of Neurosciences at Rabin Medical Center, and Dr. Yosef Levy. Commercialized by Brainstorm Cell Therapeutics based in Tel Aviv, NurOwn actually produces the missing chemical that enables restoration of motor movement.

Related Articles

New Evidence: Mobile Phones May Up Brain Cancer Risk


A study in Antioxidants & Redox Signaling provides a bit more evidence suggesting that using mobile phones or cell phones in the U.S. can boost the risk of brain cancer.
by Jimmy Downs


read more »

Genetic Testing: Fact and Fiction


One of the major roles of genetic testing in today's modern world is to provide a simple and easy method of diagnosing genetic diseases in order to save lives.


read more »

The Heart and the Computer


“We are on the way to the big bang in cardiology: artificial intelligence and the development of breakthrough engineering and genetic technologies are expected to be at the forefront of the future war on cardiovascular diseases.”


read more »